Glypican 3 binds to GLUT1 and decreases glucose transport activity in hepatocellular carcinoma cells

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1252-1259

  Cho, Hye Sim ^a   Ahn, Jung Mo ^a   Han, Ho Jae ^b   Cho, Je Yoel ^a  

^a Kyungpook National University   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

glucose uptake; GLUT1; glypican 3; hepatoma; proteomics

Indexed keywords

COMPLEMENTARY DNA; GLUCOSE TRANSPORTER 1; GLYPICAN 3;

ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CELL STRAIN HEPG2; CONTROLLED STUDY; DISSOCIATION CONSTANT; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SURFACE PLASMON RESONANCE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CELL LINE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYPICANS; HEP G2 CELLS; HUMANS; INSECTS; LIVER NEOPLASMS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEOMICS; TRANSFECTION;

HEXAPODA;

EID: 78649840901     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22848     Document Type: Article

References (35)

1. Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Scholmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C,. 2009. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 174: 1544-1552.
2. Berggard T, Linse S, James P,. 2007. Methods for the detection and analysis of protein-protein interactions. Proteomics 7: 2833-2842.
3. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M,. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777.
4. Bradford MM,. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Capurro M, Filmus J,. 2005. Glypican-3 as a serum marker for hepatocellular carcinoma. Cancer Res 65: 372; author reply 372-373.
6. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J,. 2003. Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125: 89-97.
7. Capurro MI, Xu P, Shi W, Li F, Jia A, Filmus J,. 2008. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell 14: 700-711.
8. Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM,. 2008. Glypican-3-mediated oncogenesis involves the insulin-like growth factor-signaling pathway. Carcinogenesis 29: 1319-1326.
9. Chirayath MV, Gajdzik L, Hulla W, Graf J, Cross HS, Peterlik M,. 1998. Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in Caco-2 cell cultures. Am J Physiol 274: G389-G396.
10. Cho JY, Lee M, Ahn JM, Park ES, Cho JH, Lee SJ, Kim BG, Heo SH, Park HJ, Zerbini LF, Hwang D, Libermann TA,. 2009. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex. J Proteome Res 8: 1327-1337.
11. Filmus J, Selleck SB,. 2001. Glypicans: Proteoglycans with a surprise. J Clin Invest 108: 497-501.
12. Flier JS, Mueckler MM, Usher P, Lodish HF,. 1987. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492-1495.
13. Haney PM, Levy MA, Strube MS, Mueckler M,. 1995. Insulin-sensitive targeting of the GLUT4 glucose transporter in L6 myoblasts is conferred by its COOH-terminal cytoplasmic tail. J Cell Biol 129: 641-658.
14. Heo JS, Han HJ,. 2006. PKC and MAPKs pathways mediate EGF-induced stimulation of 2-deoxyglucose uptake in mouse embryonic stem cells. Cell Physiol Biochem 17: 145-158.
15. Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY,. 2007. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7: 4292-4302.
16. Keller RA, Ambrose WP, Arias AA, Cai H, Emory SR, Goodwin PM, Jett JH,. 2002. Analytical applications of single-molecule detection. Anal Chem 74: 316A-324A.
17. Kim BG, Lee JH, Ahn JM, Park SK, Cho JH, Hwang D, Yoo JS, Yates JR III, Ryoo HM, Cho JY,. 2009. 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast. J Proteome Res 8: 4441-4454.
18. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF,. 1985. Sequence and structure of a human glucose transporter. Science 229: 941-945.
19. Nakano K, Orita T, Nezu J, Yoshino T, Ohizumi I, Sugimoto M, Furugaki K, Kinoshita Y, Ishiguro T, Hamakubo T, Kodama T, Aburatani H, Yamada-Okabe H, Tsuchiya M,. 2009. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem Biophys Res Commun 378: 279-284.
20. Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, Nishimura Y,. 2003. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun 306: 16-25.
21. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, Senju S, Ono T, Nishimura Y,. 2004. Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 10: 6612-6621.
22. Nesvizhskii AI, Keller A, Kolker E, Aebersold R,. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
23. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D,. 1996. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12: 241-247.
24. Qoronfleh MW, Benton B, Ignacio R, Kaboord B,. 2003. Selective enrichment of membrane proteins by partition phase separation for proteomic studies. J Biomed Biotechnol 4: 249-255.
25. Roh MS, Jeong JS, Kim YH, Kim MC, Hong SH,. 2004. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas. Hepatogastroenterology 51: 1315-1318.
26. Saleem Y, Kim KS,. 2009. RGS11 interacts preferentially with R7BP over Galpha(oa)-Characterization of Gbeta5-free RGS11. Biochem Biophys Res Commun 386: 65-70.
27. Stigliano I, Puricelli L, Filmus J, Sogayar MC, Bal de Kier Joffe E, Peters MG,. 2009. Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation. Breast Cancer Res Treat 114: 251-262.
28. Suganuma N, Segade F, Matsuzu K, Bowden DW,. 2007. Differential expression of facilitative glucose transporters in normal and tumour kidney tissues. BJU Int 99: 1143-1149.
29. Sung YK, Hwang SY, Park MK, Farooq M, Han IS, Bae HI, Kim JC, Kim M,. 2003. Glypican-3 is overexpressed in human hepatocellular carcinoma. Cancer Sci 94: 259-262. (Pubitemid 36575892)
30. Taguchi A, Emoto M, Okuya S, Fukuda N, Nakamori Y, Miyazaki M, Miyamoto S, Tanabe K, Aburatani H, Oka Y, Tanizawa Y,. 2008. Identification of glypican3 as a novel GLUT4-binding protein. Biochem Biophys Res Commun 369: 1204-1208.
31. Tal M, Thorens B, Surana M, Fleischer N, Lodish HF, Hanahan D, Efrat S,. 1992. Glucose transporter isotypes switch in T-antigen-transformed pancreatic beta cells growing in culture and in mice. Mol Cell Biol 12: 422-432.
32. Wang XY, Degos F, Dubois S, Tessiore S, Allegretta M, Guttmann RD, Jothy S, Belghiti J, Bedossa P, Paradis V,. 2006. Glypican-3 expression in hepatocellular tumors: Diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 37: 1435-1441.
33. Wood IS, Trayhurn P,. 2003. Glucose transporters (GLUT and SGLT): Expanded families of sugar transport proteins. Br J Nutr 89: 3-9.
34. Xiang YY, Ladeda V, Filmus J,. 2001. Glypican-3 expression is silenced in human breast cancer. Oncogene 20: 7408-7412.
35. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, Hippo Y, Kodama T, Iwanari H, Aburatani H, Fukayama M,. 2005. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 18: 1591-1598.